Uploaded February 2025 | Updated September 2026, 2 weeks ago

---

Antibody Drug Conjugates (ADCs) – Revolutionizing Cancer Treatment

Antibody Drug Conjugates (ADCs) are transforming cancer therapy by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. This video explores how ADCs work, their advantages over traditional chemotherapy, the challenges in their development, and the critical role of analytical services in ensuring their safety and efficacy.

🔹 What You’ll Learn in This Video:
✔️ Components of ADCs: Antibody, linker, and payload
✔️ Advantages of ADCs in targeted drug delivery
✔️ Key challenges in ADC development (stability, Drug-Antibody Ratio, resistance mechanisms)
✔️ Importance of analytical testing (serum stability studies, PK/TK analysis, LC-MS/MS, immunoassays)

As a leader in ADC characterization, Emery Pharma provides cutting-edge analytical services to support ADC development from early-stage research to clinical applications.

📩 For More Information:
🌐 Visit: emerypharma.com
📧 Email: info@emerypharma.com
📞 Call: 1-888-98-EMERY (36379) | +1 (510) 899-8814
📍 Address: 1000 Atlantic Ave, Suite #110, Alameda, CA 94501 USA

🔔 Don’t forget to like, comment, and subscribe for more insights into cutting-edge pharmaceutical research!